vimarsana.com

Latest Breaking News On - சிஇஆர்இபிஆர்ஓவிஏஎஸ்சியுவ்எல்ஏஆர் நோய் - Page 2 : vimarsana.com

Bone marrow cell injections may lead to reduction in brain injury after stroke

Bone marrow cell injections may lead to reduction in brain injury after stroke Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke. The study was conducted by Muhammad E. Haque, Ph.D., Sean I. Savitz, M.D., and colleagues from the Institute for Stroke and Cerebrovascular Disease at The University of Texas Health Science Center in Houston. Nearly 90 percent of patients who suffer an ischemic stroke - the most common type of stroke - exhibit weakness or paralysis to one side of the body. Injuries to the corticospinal tract (CST), which is the main white matter connection in the brain responsible for carrying movement-related information to the spinal cord, is the primary cause of this motor function impairment. In stroke animal models, we ve seen how bone marrow mononuclear cells (BM-MNC) attenuate secondary degeneration and en

Study provides evidence that bone marrow cell injections help heal the brain after stroke

 E-Mail IMAGE: Autologous bone-marrow mononuclear cells were intravenously administered in patients with acute ischemic stroke as procedure outline in panel A. The non-treated patients were recruited separately. Both groups were imaged. view more  Credit: AlphaMed Press Durham, NC - Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke. The study was conducted by Muhammad E. Haque, Ph.D., Sean I. Savitz, M.D., and colleagues from the Institute for Stroke and Cerebrovascular Disease at The University of Texas Health Science Center in Houston. Nearly 90 percent of patients who suffer an ischemic stroke - the most common type of stroke - exhibit weakness or paralysis to one side of the body, Dr. Haque said. Injuries to the corticospinal tract (CST), which is the main white matter connection in the brain responsibl

DiaMedica Therapeutics Hosting Key Opinion Leader Webinar on DM199 for Treatment of Acute Ischemic Stroke

Press release content from Business Wire. The AP news staff was not involved in its creation. DiaMedica Therapeutics Hosting Key Opinion Leader Webinar on DM199 for Treatment of Acute Ischemic Stroke March 9, 2021 GMT MINNEAPOLIS (BUSINESS WIRE) Mar 9, 2021 DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage biopharmaceutical company developing novel treatments for neurological and kidney diseases, today announced that it will host a key opinion leader (KOL) webinar on DM199, the Company’s lead asset for the treatment of Acute Ischemic Stroke (AIS), on Friday, March 19, 2021 at 12:00pm Eastern Time. The webinar will feature presentations by KOLs Scott Kasner, M.D., University of Pennsylvania, and Paolo Madeddu, M.D., University of Bristol, who will discuss the current treatment landscape and unmet medical need in treating patients with AIS and the rationale for the treatment of stroke and stroke recurrence with DM199. Drs. Kasner and Madeddu will be available to answ

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.